SCHEMBL14346014

SCHEMBL14346014

CSP(C)(=O)OCCN(C(C)C)C(C)C

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CHRM2 P08172 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14346049 1.00 MEN1 (0.32) MEN1KMT2ACHRM2CHRM1CHRM3
SCHEMBL14346017 1.00 MEN1 (0.32) MEN1KMT2ACHRM2CHRM1CHRM3
SCHEMBL9315314 0.81 MEN1 (0.30) MEN1KMT2A
SCHEMBL3988371 0.76 MEN1 (0.34) MEN1KMT2ACHRM2CHRM1CHRM3
SCHEMBL4454861 0.76 MEN1 (0.34) MEN1KMT2ACHRM2CHRM1CHRM3
SCHEMBL27256342 0.74 LPAR3 (0.42) MEN1KMT2ACHRM2CHRM1CHRM3
SCHEMBL28992248 0.74 MEN1 (0.36) MEN1KMT2ACHRM2CHRM1CHRM3
SCHEMBL7159583 0.73 TSHR (0.34) MEN1KMT2ACHRM2CHRM1CHRM3
SCHEMBL15086924 0.72
SCHEMBL28992249 0.71 CHRM2 (0.34) MEN1KMT2ACHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007146003-A2 METHODS FOR ESTER DETOXICATION HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2007-12-21 WO disclosed
US-20070286846-A1 Novel methods for ester detoxication HUMAN BIOMOLECULAR RESEARCH INSTITUTE 2007-12-13 US disclosed
US-20070286846-A1 Novel methods for ester detoxication HUMAN BIOMOLECULAR RESEARCH INSTITUTE 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070286846-A1 Novel methods for ester detoxication CES2, BCHE, ACHE MEN1 4804/4885KMT2A 2377/4885CHRM2 778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.